Viridian Therapeutics, Inc. VRDN Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s share-based payment award options outstanding - number?
- Viridian Therapeutics, Inc. (VRDN) reported share-based payment award options outstanding - number of 16.7M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s share-based payment award options outstanding - number changed year-over-year?
- Viridian Therapeutics, Inc.'s share-based payment award options outstanding - number increased by 18.6% year-over-year, from 14.1M to 16.7M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.